Lv1
20 积分 2025-05-17 加入
The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck
12小时前
已完结
Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial
13小时前
已完结
Abstract CT058: Final results of a first-in-human (FIH) study of intratumoral pan-ErbB-targeted CAR-T cell therapy for head and neck squamous cell carcinoma (HNSCC): T4 immunotherapy
2个月前
已完结
Abstract CT058: Final results of a first-in-human (FIH) study of intratumoral pan-ErbB-targeted CAR-T cell therapy for head and neck squamous cell carcinoma (HNSCC): T4 immunotherapy
2个月前
已关闭
CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma
3个月前
已完结
Strategic approaches in oral squamous cell carcinoma diagnostics using liquid biopsy
5个月前
已完结
Biological biomarkers of oral cancer
5个月前
已完结
The oral microbiota and its role in carcinogenesis
5个月前
已完结
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma
5个月前
已完结
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma
5个月前
已完结
皖公网安备34019202002308
